A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation - Concepedia

Concepedia

Publication | Closed Access

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

200

Citations

19

References

2009

Year

Brian Thiessen, Clinton F. Stewart, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Paula Schaiquevich, Warren Mason, Jacob C. Easaw, Karl Bélanger, Peter Forsyth, L. McIntosh,

Cancer Chemotherapy and Pharmacology

OncologyMolecular CorrelationMedicinePathologyClinical OutcomesAnti-cancer AgentHigh-grade GliomasPhase I/ii TrialCancer TreatmentRadiation OncologyPharmacologyGliomaHealth Sciences

References

	Year	Citations

Page 1

Page 1